Home » Topics » Regulatory » Patents

Patents
RSS

reMYND develops new compounds for protein-misfolding disorders

Oct. 1, 2015

Merck & Co. and Merck Frosst Canada report HIV protease inhibitors

Sep. 30, 2015

Principia Biopharma reports TXK and ITK inhibitors

Sep. 30, 2015

Department of Health of the U.K. and JNCASR describe antimicrobial conjugates

Sep. 30, 2015

IURTC and Assembly Biosciences patent HBV core protein allosteric modulators

Sep. 30, 2015

FORUM Pharmaceuticals presents gamma-secretase modulators

Sep. 29, 2015

Icahn School of Medicine at Mount Sinai describes PP2A activators

Sep. 29, 2015

AbbVie Deutschland discloses 5-HT2C receptor agonists

Sep. 29, 2015

Takeda Pharmaceutical reports development of acyl-CoA desaturase inhibitors

Sep. 29, 2015

Columbia University in the City of New York patents MOR-1 agonists

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...